© 2025 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY
WEDW-FM · WNPR · WPKT · WRLI-FM
Public Files Contact · ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Only one-third of people eligible to take life-saving statins are doing so

STEVE INSKEEP, HOST:

We have a story now about statin medications that help to lower cholesterol. Only about one-third of people eligible to take them do, according to a study published in the Annals of Internal Medicine. NPR's Allison Aubrey reports.

ALLISON AUBREY, BYLINE: The FDA approved the first commercial statin medication back in the late 1980s. And since that time, there's been a lot of evidence that the medications can significantly reduce the risk of having a heart attack or a stroke, says primary care doctor Tim Anderson of the University of Pittsburgh.

TIM ANDERSON: Generally, statins, when taken regularly, will drop cholesterol levels 30 to 40%. Statins are the most effective tool in our toolkit to try to help folks reduce that chance of a heart attack or a stroke down the road.

AUBREY: Yet millions of people who could benefit don't use them. And Anderson wanted to nail this down. So he and his collaborators analyzed data from the National Health and Nutrition Examination Survey. They found that over the last 10 years, the use of statins, even for primary prevention, meaning among those who've not yet had a heart attack or stroke but are at high risk, has trailed off. Only about 35% of people who are eligible use them, even as generic versions have lowered the cost of the medicines.

ANDERSON: What's surprising here is that it's fully leveled off, and that has even happened as statins have become more affordable. And so that leveling off is quite surprising.

AUBREY: There are a bunch of reasons why people who are eligible may not take statins. Some are not aware they could benefit. In primary care visits, providers can calculate a patient's 10-year risk of having a cardiovascular event, which is one measure used to determine who's a good candidate to be on a statin.

ANDERSON: As we age, most, if not all, folks' cholesterol slowly rises, even with healthy lifestyle. And so one of the reasons we talk about cholesterol in folks in their 40s, 50s and 60s is really that even with healthy lifestyle, we know cholesterol levels and that risk creep up.

AUBREY: Some people hesitate to take a statin due to concerns about side effects, but Anderson says doses can be adjusted to minimize this, and most people tolerate the medications. Other people turn to lifestyle changes in lieu of medicines.

ANDERSON: For some patients, we can reduce cholesterol through things like changing diet and regular exercise. But for many folks, even when following those heart-healthiest diets, cholesterol often still runs in families, so there's a genetic component to that.

AUBREY: So it may be hard to bring down levels enough. Anderson says understanding the risks and benefits of statins is something people can ask their providers about before their risk creeps up.

Allison Aubrey, NPR News.

(SOUNDBITE OF MUSIC) Transcript provided by NPR, Copyright NPR.

NPR transcripts are created on a rush deadline by an NPR contractor. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Allison Aubrey is a correspondent for NPR News, where her stories can be heard on Morning Edition and All Things Considered. She's also a contributor to the PBS NewsHour and is one of the hosts of NPR's Life Kit.

The independent journalism and non-commercial programming you rely on every day is in danger.

If you’re reading this, you believe in trusted journalism and in learning without paywalls. You value access to educational content kids love and enriching cultural programming.

Now all of that is at risk.

Federal funding for public media is under threat and if it goes, the impact to our communities will be devastating.

Together, we can defend it. It’s time to protect what matters.

Your voice has protected public media before. Now, it’s needed again. Learn how you can protect the news and programming you depend on.

SOMOS CONNECTICUT is an initiative from Connecticut Public, the state’s local NPR and PBS station, to elevate Latino stories and expand programming that uplifts and informs our Latino communities. Visit CTPublic.org/latino for more stories and resources. For updates, sign up for the SOMOS CONNECTICUT newsletter at ctpublic.org/newsletters.

SOMOS CONNECTICUT es una iniciativa de Connecticut Public, la emisora local de NPR y PBS del estado, que busca elevar nuestras historias latinas y expandir programación que alza y informa nuestras comunidades latinas locales. Visita CTPublic.org/latino para más reportajes y recursos. Para noticias, suscríbase a nuestro boletín informativo en ctpublic.org/newsletters.

The independent journalism and non-commercial programming you rely on every day is in danger.

If you’re reading this, you believe in trusted journalism and in learning without paywalls. You value access to educational content kids love and enriching cultural programming.

Now all of that is at risk.

Federal funding for public media is under threat and if it goes, the impact to our communities will be devastating.

Together, we can defend it. It’s time to protect what matters.

Your voice has protected public media before. Now, it’s needed again. Learn how you can protect the news and programming you depend on.